Press Release

BOSTON and LONDON – June 4, 2024 (GLOBE NEWSWIRE) – Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for …

[Read more...] about Akari Therapeutics Secures $7.6 Million in Upsized Financing Round

BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune …

[Read more...] about Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

BOSTON and PLEASANTON, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX, “Akari”) and Peak Bio Inc. (OTC: PKBO, “Peak”) today …

[Read more...] about Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

BOSTON and LONDON, March 15, 2024 (GLOBE NEWSWIRE) – Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for …

[Read more...] about Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024